DMAAU

Drugs Made In America Acquisition Corp. Units

Insider Trades

Name	Value	Action	Price	Current Price
Stockwell LynnDirector, 10 Percent Owner, Officer: CEO And Exe. Chair Of Board Disclosure amount unavailable30k shares BuyFeb 18, 2025 -- $10.99
Drugs Made In America Acquisition LLC10 Percent Owner Disclosure amount unavailable30k shares BuyFeb 18, 2025 -- $10.99
Stockwell LynnDirector, 10 Percent Owner, Officer: CEO And Executive COB $9M5.7M shares SellJan 29, 2025 $1.50 $10.99
Drugs Made In America Acquisition LLC10 Percent Owner $9M5.7M shares SellJan 29, 2025 $1.50 $10.99
Stockwell LynnDirector, 10 Percent Owner, Officer: CEO And Executive COB Disclosure amount unavailable400k shares BuyJan 29, 2025 -- $10.99
Drugs Made In America Acquisition LLC10 Percent Owner Disclosure amount unavailable400k shares BuyJan 29, 2025 -- $10.99

Trade DMAAU

About Drugs Made In America Acquisition Corp. Units

Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises. The firm was established on May 23, 2024, and maintains its principal office in Fort Lauderdale, Florida.

CEO: Roger Bendelac
IPO Date: Jan 27, 2025

Market Data

Open: $10.69
High: $10.69
Low: $10.61
Volume: 2.1K
Avg Volume: 659
52W High: $12.50
52W Low: $10.30

Valuation

Market Cap: $360.4M
Enterprise Value: $358.5M
Dividend Yield: 0.00%

Financials

Free Cash Flow: -$539.2K
Revenue: $0
Net Income: $5.9M
Cash: $6.1K
Debt: $0

Events

IPOJan 27

NASDAQ